gWiz_BM40-vGAT-VL-hIgG1-CL
(Plasmid
#218437)
-
Purposemammalian expression plasmid for the light chain fragment of an anti-vGAT Fab domain
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 218437 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonegWiz
-
Vector typeMammalian Expression, Affinity Reagent/ Antibody
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namevGAT-VL-hIgG1-CL
-
Alt namelight chain fragment of an anti-vGAT Fab domain
-
SpeciesSynthetic
- Promoter CMV
-
Tag
/ Fusion Protein
- BM40 (N terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
A portion of this plasmid was derived from a plasmid made byNeuroMab Seq (https://neuromabseq.ucdavis.edu/)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Sequence derived from NeruoMab Clone #: L118/80 - NeuroMab Seq is supported by grant NIH U24 NS109113.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
gWiz_BM40-vGAT-VL-hIgG1-CL was a gift from Axel Brunger (Addgene plasmid # 218437 ; http://n2t.net/addgene:218437 ; RRID:Addgene_218437) -
For your References section:
A new method for isolation and purification of fusion-competent inhibitory synaptic vesicles. Gopal N, Leitz J, Wang C, Esquivies L, Pfuetzner RA, Brunger AT. Curr Res Physiol. 2024 Feb 23;7:100121. doi: 10.1016/j.crphys.2024.100121. eCollection 2024. 10.1016/j.crphys.2024.100121 PubMed 38572021